Scott Wilson Curtis - Net Worth and Insider Trading

Scott Wilson Curtis Net Worth

The estimated net worth of Scott Wilson Curtis is at least $29,500 dollars as of 2024-06-18. Scott Wilson Curtis is the Senior Officer of Antibe Therapeutics Inc and owns about 100,000 shares of Antibe Therapeutics Inc (TSX:ATE) stock worth over $29,500. Details can be seen in Scott Wilson Curtis's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Scott Wilson Curtis has not made any transactions after 2022-11-15 and currently still holds the listed stock(s).

Transaction Summary of Scott Wilson Curtis

To

Scott Wilson Curtis Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Scott Wilson Curtis owns 1 companies in total, including Antibe Therapeutics Inc (TSX:ATE) .

Click here to see the complete history of Scott Wilson Curtis’s form 4 insider trades.

Insider Ownership Summary of Scott Wilson Curtis

Ticker Comapny Transaction Date Type of Owner
TSX:ATE Antibe Therapeutics Inc 2022-11-15 Senior Officer

Scott Wilson Curtis Latest Holdings Summary

Scott Wilson Curtis currently owns a total of 1 stock. Scott Wilson Curtis owns 100,000 shares of Antibe Therapeutics Inc (TSX:ATE) as of November 15, 2022, with a value of $29,500.

Latest Holdings of Scott Wilson Curtis

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSX:ATE Antibe Therapeutics Inc 2022-11-15 100,000 0.30 29,500

Holding Weightings of Scott Wilson Curtis


Scott Wilson Curtis Form 4 Trading Tracker

According to the SEC Form 4 filings, Scott Wilson Curtis has made a total of 9 transactions in Antibe Therapeutics Inc (TSX:ATE) over the past 5 years, including 7 buys and 2 sells. The most-recent trade in Antibe Therapeutics Inc is the acquisition of 20,000 shares on November 15, 2022, which cost Scott Wilson Curtis around $10,000.

Insider Trading History of Scott Wilson Curtis

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Scott Wilson Curtis Trading Performance

GuruFocus tracks the stock performance after each of Scott Wilson Curtis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Scott Wilson Curtis is -26.23%. GuruFocus also compares Scott Wilson Curtis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Scott Wilson Curtis within 3 months outperforms 1 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Scott Wilson Curtis's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Scott Wilson Curtis

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 8 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -11.97 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -13.27 LIMIT LIMIT LIMIT LIMIT LIMIT

Scott Wilson Curtis Ownership Network

Ownership Network List of Scott Wilson Curtis

No Data

Ownership Network Relation of Scott Wilson Curtis

Insider Network Chart

Scott Wilson Curtis Owned Company Details

What does Antibe Therapeutics Inc do?

Who are the key executives at Antibe Therapeutics Inc?

Scott Wilson Curtis is the Senior Officer of Antibe Therapeutics Inc. Other key executives at Antibe Therapeutics Inc include Director & Director or Senior Officer of 10% Security Holder & Senior Officer John Lawrence Wallace , Senior Officer Joseph Stauffer , and Senior Officer Daniel Marcel Legault .

Antibe Therapeutics Inc (TSX:ATE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Antibe Therapeutics Inc (TSX:ATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antibe Therapeutics Inc (TSX:ATE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Antibe Therapeutics Inc (TSX:ATE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Antibe Therapeutics Inc Insider Transactions

No Available Data

Scott Wilson Curtis Mailing Address

Above is the net worth, insider trading, and ownership report for Scott Wilson Curtis. Currently GuruFocus does not have mailing address information for Scott Wilson Curtis.

Discussions on Scott Wilson Curtis

No discussions yet.